| Status | In progress |
| Process | STA 2018 |
| ID number | 1440 |
Provisional Schedule
| Committee meeting: 1 | 26 November 2019 |
| Expected publication | 19 February 2020 |
Project Team
| Project lead | Jeremy Powell |
Email enquiries
- If you have any queries please email TAcommb@nice.org.uk
| Evidence Review Group / Assessment Group | Health Economics Research Unit and Health Services Research Unit, University of Aberdeen |
Consultees
| Companies sponsors | Medtronic (TYRX Absorbable Antibacterial Envelope) |
| Others | Department of Health and Social Care |
| NHS England | |
| NHS Leicester City CCG | |
| NHS Newham CCG | |
| Welsh Government | |
| Patient carer groups | Arrhythmia Alliance |
| Atrial Fibrillation Association | |
| British Cardiac Patients Association | |
| British Heart Foundation | |
| Blood Pressure UK | |
| Cardiac Risk in Young Children | |
| Cardiomyopathy UK | |
| Cardiovascular Care Partnership | |
| HEART UK | |
| Muslim Council of Britain | |
| Pumping Marvellous Foundation | |
| Royal College of Surgeons Patient Liaison Group | |
| The Ashley Jolly SADS UK Trust | |
| The Sepsis Trust | |
| Somerville Foundation | |
| South Asian Health Foundation | |
| Specialised Healthcare Alliance | |
| UK Health Forum | |
| Professional groups | Association of Anaesthetists |
| Association of Surgeons of Great Britain and Ireland | |
| British Association for Nursing in Cardiovascular Care | |
| British Cardiovascular Society | |
| British Geriatrics Society | |
| British Heart Foundation | |
| British Heart Rhythm Society | |
| British Nuclear Cardiology Society | |
| The British Society for Heart Failure | |
| Royal College of Emergency Medicine | |
| Royal College of General Practitioners | |
| Royal College of Anaesthetists | |
| Royal College of Nursing | |
| Royal College of Pathologists | |
| Royal College of Physicians | |
| Royal College of Surgeons of England | |
| Royal Pharmaceutical Society | |
| Royal Society of Medicine | |
| Society for Cardiological Science and Technology | |
| Society for Cardiothoracic Surgery in Great Britain and Ireland | |
| UK Health Forum | |
| Society of Cardiothoracic Surgeons | |
| UK Clinical Pharmacy Association |
Commentators
| Associated public health groups | Public Health England |
| Public Health Wales | |
| Comparator companies | Accord UK (vancomycin) |
| Flynn Pharma (vancomycin) | |
| Sanofi (gentamicin, teicoplanin) | |
| Syntacoll GmbH (Collatamp G) | |
| Wockhardt UK (flucloxacillin, gentamicin, vancomycin) | |
| General commentators | All Wales Therapeutics and Toxicology Centre |
| Allied Health Professionals Federation | |
| Association of British Healthcare Industries | |
| Board of Community Health Councils in Wales | |
| British National Formulary | |
| Care Quality Commission | |
| Department of Health, Social Services and Public Safety for Northern Ireland | |
| EUCOMED | |
| Healthcare Improvement Scotland | |
| Medicines and Healthcare products Regulatory Agency | |
| National Association of Primary Care | |
| National Pharmacy Association | |
| NHS Alliance | |
| NHS Confederation | |
| NHS Supply Chain | |
| Royal College of Physicians of Edinburgh | |
| Royal College of Surgeons of Edinburgh | |
| Scottish Medicines Consortium | |
| Welsh Health Specialised Services Committee | |
| Relevant research groups | British Society for Cardiovascular Research |
| Cardiac and Cardiology Research Dept, Barts | |
| Cochrane Heart Group | |
| National Centre for Cardiovascular Preventions and Outcomes | |
| Heart Research UK | |
| MRC Clinical Trials Unit | |
| National Institute for Health Research | |
| Wellcome Trust |
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 29 March 2019 | Invitation to participate |
| 29 March 2019 | In progress, The invitation to participate went out to the stakeholders. |
| 13 September 2018 (10:00) | Scoping workshop (London) |
| 23 July 2018 - 20 August 2018 | Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators |
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance